Forslund, Maria

Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · European Journal of Endocrinology

Ovarian function and disordersClinical practice guidelines implementation

Cited by 525

Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Tay, C. T., Laven, J., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., M. Redman, L., A. Boyle, J., et al. (2023) · Fertility and Sterility

Ovarian function and disordersClinical practice guidelines implementation

Cited by 417

Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede, H. J., Tay, C. T., Laven, J., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · Human Reproduction

Ovarian function and disordersClinical practice guidelines implementation

Cited by 244

Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis

Melin, J., Forslund, M., Alesi, S., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A., Witchel, S. F., Mousa, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 78

The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials

Melin, J., Forslund, M., Alesi, S., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A., Witchel, S. F., Mousa, A., et al. (2023) · European Journal of Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 72

Type 2 diabetes mellitus in women with polycystic ovary syndrome during a 24-year period: importance of obesity and abdominal fat distribution

Forslund, M., Landin-Wilhelmsen, K., Trimpou, P., Schmidt, J., Brännström, M., & Dahlgren, E. (2020) · Human Reproduction Open

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 66

Higher menopausal age but no differences in parity in women with polycystic ovary syndrome compared with controls

Forslund, M., Landin‐Wilhelmsen, K., Schmidt, J., Brännström, M., Trimpou, P., & Dahlgren, E. (2019) · Acta Obstetricia Et Gynecologica Scandinavica

Ovarian function and disordersReproductive Biology and Fertility

Cited by 60

Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: a systematic review

Forslund, M., Melin, J., Alesi, S., Piltonen, T., Romualdi, D., Tay, C. T., Witchel, S., Pena, A., Mousa, A., & Teede, H. (2023) · Clinical Endocrinology

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 32

Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta‐analysis

Melin, J. M., Forslund, M., Alesi, S. J., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A. S., Witchel, S. F., Mousa, A., et al. (2024) · Clinical Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 16

Supplementary Material. Metformin and combined oral contraceptive pills in the management of polycystic ovary syndrome: a systematic review and meta-analysis.

Melin, J., Forslund, M., Alesi, S., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena Vargas, A., Witchel, S. F., Mousa, A., et al. (2023) · Monash University

Ovarian function and disordersEndometriosis Research and Treatment

Cited by 0